Recent changes to the Medicare Part B Outpatient Prospective Payment System reimbursement system will end up benefiting hospitals, according to a new study.
The analysis by Avalere finds that 85 percent of hospitals will “see a net increase in their overall Medicare Part B reimbursement.”
The findings may come as a surprise to the many in the medical field who loudly protested the recent changes to the 340B program, which requires drug companies to provide discounted drugs to hospitals that serve a large population of low-income patients. Until Jan. 1, 340B hospitals were reimbursed by the federal government at the full market rate of the drugs, plus 4.3 percent, providing them additional money that they are supposed to invest in improving service for low-income patients.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
